logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Mosanna Therapeutics Appoints David Weber As Chief Executive Officer

Jun 09, 2025•6 months ago

Position

Chief Executive Officer

Company

Mosanna Therapeutics

David Weber
Redwood CityBiotechnology

Description

Mosanna Therapeutics has announced the appointment of David Weber, Ph.D., as Chief Executive Officer. This leadership change comes as the company closes $80 million in Series A funding to advance its innovative sleep apnea treatment, MOS118.

Company Information

Company

Mosanna Therapeutics

Location

Redwood City, California, United States

About

Mosanna Therapeutics is a clinical-stage biotech company pioneering a novel pharmaceutical approach to treating obstructive sleep apnea (OSA) with an easily administered nasal spray. Designed to help restore the body's natural airway control during sleep, Mosanna's lead therapy, MOS118, offers a drug-based alternative to traditional mechanical treatments and is currently being evaluated in a Phase 1 clinical trial. Founded in 2022, the company has raised more than $80 million from investors including Pivotal bioVenture Partners, EQT Life Sciences, Forbion, Norwest, Broadview Ventures, Forty51 Ventures, Supermoon Capital and High-Tech Gründerfonds (HTGF). Mosanna has offices in Redwood City, California and Basel, Switzerland.

Related People

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months